Although it functions to initiate appropriate innate and adaptive immune responses, aberrant expression of IL-1β has been implicated in the development of many diseases, including autoimmune conditions, metabolic disorders, and cardiovascular disease. This evidence concerns the gene IL1B and metabolic disease.